ATH 25.0% 0.5¢ alterity therapeutics limited

Final Report says that the initial MJFF Grant for PBT434 was to...

  1. 158 Posts.
    Final Report says that the initial MJFF Grant for PBT434 was to cover the calendar year 2013, for which we had much earlier met all the milestones.

    Shake-it-up Australia site mentions something about having projects in final approval stage.

    I believe the report also had changed the target wording from First in Human trials from 2015 to by the end of 2014, a slightly more aggressive target. Wonder on what basis they could make that statement change?

    So hoping the timing is right for a positive catalyst.

    A second pipeline drug moving toward human testing through a follow-on grant commitment from MJFF or a partner in a 4 Billion market would be quite a nice catalyst and should put Prana Biotech in a new league - greatly reducing the risk associated with a single drug pipeline company.

    I have not idea, but the timing sure seems about right for this type of news.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $625 125K

Buyers (Bids)

No. Vol. Price($)
63 72318906 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 29668676 22
View Market Depth
Last trade - 10.00am 09/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.